AMGEN INC. v. MACLEODS PHARMACEUTICALS LTD. > Summary
Court Case Number 3:18-cv-11212
Filing Date Jun 28, 2018
Termination Date Aug 14, 2020
Court New Jersey District Court
Status Dismissed - Settled
Defendant
Plaintiff Attorneys
13Amgen
Attorney Name: Charles H. Chevalier
Gibbons P.C.
Amgen
Attorney Name: Christine A. Gaddis
Gibbons P.C.
Celgene
Attorney Name: Sarah A. Sullivan
Saul Ewing LLP
Celgene
Attorney Name: George F. Pappas
Covington & Burling LLP
Celgene
Attorney Name: Christopher N. Sipes
Covington & Burling LLP
Celgene
Attorney Name: Michael N. Kennedy
Covington & Burling LLP
Celgene
Attorney Name: Alexa R. Hansen
Covington & Burling LLP
Amgen
Attorney Name: Eric M. Agovino
Amgen
Amgen
Attorney Name: Christina N. Gifford
Amgen
Amgen
Attorney Name: Wendy A. Whiteford
Amgen
Attorney Name: Charles M. Lizza
Attorney Name: Sarah A. Geers
Attorney Name: Christina N. Gifford
Defendant Attorneys
6Macleods Pharmaceuticals Ltd
Attorney Name: Bisma Muhammed
Sills Cummis & Gross
Macleods Pharmaceuticals Ltd
Attorney Name: Mark S. Olinsky
Sills Cummis & Gross
Macleods Pharmaceuticals Ltd
Attorney Name: Bruce Jefferson Boggs Jr.
Merchant & Gould
Macleods Pharmaceuticals Ltd
Attorney Name: Christopher J. Sorenson
Merchant & Gould
Attorney Name: Bruce Jefferson Boggs Jr.
Counter Defendant
4Celgene
Attorney Name: William C. Baton
Saul Ewing LLP
Celgene
Attorney Name: Charles M. Lizza
Saul Ewing LLP
Celgene
Attorney Name: David Leigh Moses
Saul Ewing LLP
Celgene
Attorney Name: Sarah A. Sullivan
Saul Ewing LLP
Counter Claimant
2Cause
15:1126 Patent Infringement
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 10092541 | Methods for the treatment of diseases ameliorated by PDE4 inhibition using dosage titration of apremilast | Oct 9, 2018 |
| 07427638 | (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione:, and methods of synthesis and compositions thereof | Sep 23, 2008 |
